+41%

est. 2Y upside i

HealthcareAI & MLProductivitySeries A

Invert builds software for bioprocessing. With Invert, your team has full transparency into all your bioprocess data from lab to production, including full process traceability from upstream to formulation. Your team will save time juggling manual data, get to insights faster, and collaborate seamlessly across teams and partners.

Rank

#1148

Sector

Biotechnology, Artificial Intelligence & Machine Learning, Business/Productivity Software

Est. Liquidity

~4Y

Data Quality

Data: Low

Invert's equity offer is high-risk given missing valuation data and likely need for additional funding.

Last updated: July 19, 2026

Bull (20%)+120%

IPO window or category leadership in AI bioprocess expands multiple to 12x; revenue reaches $16M in 24 months, yielding $192M exit.

Base (55%)+40%

Multiple converges to public comp average of 8x, revenue grows to $16M, but 20% dilution from future funding reduces ownership gain.

Bear (25%)-20%

Multiple compresses to 5x due to competition or macro factors; revenue stalls; dilution further erodes value, yielding $80M exit.

Est. time to liquidity~4.0 years

Preference Stack Risk

high

Funding Intensity

25750%

Total funding of $20.6M against estimated $80M valuation gives 25.8% preference overhang, significant for common shareholders.

Dilution Risk

high

With $20.6M raised and likely cash burn, additional funding within 24 months is probable, diluting existing shareholders by ~20%.

Secondary Liquidity

none

No secondary market indicated; only liquidity likely via IPO or M&A in 3-5 years.

Sales — 1 role

View all 3 open roles at Invert →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Invert's data — designed to show you've done your homework.

  • 1

    “How does Invert's platform specifically address GMP compliance compared to generic data platforms?”

  • 2

    “What is the current customer count and churn rate?”

  • 3

    “What is the expected timeline for next funding round and liquidity event?”

Community

Valuation Sentiment

Our model estimates +41% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.